Follow us for updates
© 2020 reportr.world
Read the Story →

U.S. Hopes to Start COVID-19 Vaccines in December

It could be a crucial shift.
by Agence France Presse
Nov 23, 2020
Photo/s: RF._.studio/Pexels
Shares

The United States hopes to begin coronavirus vaccinations in early December, a top government health official said Sunday, the latest positive news to emerge even as cases surge across the worst-hit nation and elsewhere around the globe.

The beginning of vaccinations could be a crucial shift in the battle against a virus that has claimed more than 1.4 million lives worldwide, including 255,000 just in the U.S., since emerging from China late last year.

Encouraging results from vaccine trials have bolstered hopes for an end to the pandemic, as nations reimpose restrictions and lockdowns that slowed the spread earlier this year but turned lives and economies upside down across the globe.

ALSO READ:

What are Vaccine Trials and How Do They Work?

A Reminder from WHO: Vaccines No 'Unicorn' Solution

Two leading vaccine candidates -- one by Pfizer and German partner BioNTech and another by U.S. firm Moderna -- have been shown to be 95% effective in trials, and Pfizer has already applied for emergency use approval from U.S. health authorities. 

Continue reading below ↓

"Our plan is to be able to ship vaccines to the immunization sites within 24 hours of approval" by the US Food and Drug Administration, Moncef Slaoui, head of the U.S. government virus vaccine effort, told CNN, pointing to possible dates of Dec. 11-12.

FDA vaccine advisors will meet Dec. 10 to discuss approval.

ALSO READ:

Pfizer: Final Results Show COVID-19 Vaccine 95% Effective

Moderna COVID-19 Vaccine Almost 95% Effective: Trial

Slaoui estimated that 20 million people across the U.S. could be vaccinated in December, with 30 million per month after that.

But top U.S. infectious disease official Anthony Fauci, who said "maybe 20 million people will be able to get vaccinated by the middle to the end of December," warned the situation could get worse before getting better if people fail to take precautions in the coming holiday season.

"We're in a very difficult situation at all levels," he told CBS's "Face the Nation."

Continue reading below ↓

Vaccines for all?

With cases surpassing 12 million in the United States, the highest in the world, many Americans were nonetheless heading to airports to travel for this week's Thanksgiving holiday, despite health officials' warnings to stay home.

Some U.S. states were imposing new restrictions, including California, where a 10 p.m. to 5 a.m. curfew took effect Saturday. New York City has closed schools again.

Texas, which earlier this month became the first state to record more than one million coronavirus cases, has called in the National Guard to support the city of El Paso.

Mayor Dee Margo announced on Twitter that the National Guard would provide backup to the county's morgue operations.

U.S. drug regulators on Saturday already gave emergency approval to a COVID-19 antibody therapy -- one used by U.S. President Donald Trump -- that could help treat those infected.

However, G20 nations were pushing for "equitable" global access to vaccines, with worries poorer nations will be left behind.

Continue reading below ↓

German Chancellor Angela Merkel said more needed to be done since no major vaccine agreements had been struck yet for poorer nations.

"We will now speak with (global vaccine alliance group) GAVI about when these negotiations will begin because I am somewhat worried that nothing has been done on that yet," Merkel told reporters on Sunday in Berlin after a virtual G20 summit hosted by Saudi Arabia.

There were signs that restrictions being imposed in certain countries were helping slow infections.

Spanish Prime Minister Pedro Sanchez, whose country has been badly hit by the pandemic, said Sunday that a strategy to curb infections was working.

Spain declared a state of emergency last month, which allowed regional governments to impose virus restrictions such as nighttime curfews.

The country has recorded fewer than 400 COVID-19 cases per 100,000 inhabitants over the last two weeks, compared to nearly 530 cases at the start of the month, he told a news conference after the G20 summit.

Continue reading below ↓

 'A mockery'

But the restrictions and mask-wearing rules have led to protests in some countries, particularly the United States, where people -- mainly Trump supporters -- have railed against closures.

U.S. media reported that hundreds of protesters gathered in Huntington Beach Saturday night, in defiance of California's newly implemented curfew.

Similar pushback has been seen elsewhere, and German Foreign Minister Heiko Maas lashed out Sunday at anti-mask protesters comparing themselves to Nazi victims, accusing them of trivializing the Holocaust and "making a mockery" of the courage shown by resistance fighters.

The harsh words came after a young woman took to the stage at a protest against coronavirus restrictions in Hanover Saturday saying she felt "just like Sophie Scholl," the German student executed by the Nazis in 1943 for her role in the resistance.

Government measures introduced to halt the spread of the coronavirus have triggered large protests in Germany, drawing in people from the far-left, conspiracy theorists, and right-wing extremists who claim the curbs infringe on their civil rights.

Continue reading below ↓

While necessary to stop the spread of the virus, restrictions have taken a heavy toll on economies across the world.

Another such warning came on Sunday from Britain's finance minister Rishi Sunak, who said the country's economy was under "enormous strain and stress."

Britain has suffered more than any other country in Europe from the coronavirus, recording more than 54,000 deaths from 1.4 million cases.

In November, Prime Minister Boris Johnson's government imposed a four-week lockdown to stop the spread of the disease. That is due to be partially lifted on December 2, giving some relief to businesses.

Latest Headlines
Read Next
Recent News
The company's different divisions saw growth in the last quarter of 2020.
What's it like to get vaccinated with Sinovac?
The news. So what? Subscribe to the newsletter that explains what the news means for you.
The email address you entered is invalid.
Thank you for signing up to On Three, reportr's weekly newsletter delivered to your mailbox three times a week. Only the latest, most useful and most insightful reads.
By signing up to reportr.world newsletter, you agree to our Terms of Service and Privacy Policy.